TCTR20190511002招募中1 期
A Randomized Controlled Trial of Umbilical Cord Milking versus Immediate Umbilical Cord Clamping in Preterm infants of Multiple Births Delivered by Cesarean Section
Faculty of Medicine Ramathibodi Hospital0 个研究点目标入组 68 人开始时间: 2019年5月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 N/A (No limit) 至 0 N/A (No limit)（—）
- 性别
- Female
入选标准
- •Pregnant woman with twin gestations who deliver preterm infants at gestational age of 28-36+6 weeks gestation by cesarean section.
排除标准
- •Prenatally diagnosed major congenital anomaly in any infants, twin to twin transfusion syndrome (TTTS), twin anemic polycythemic sequence (TAPS), discordant twin (weight differance more than 20%), hydrops fetalis, antepartum or intrapartum hemorrhage sush as placetal abruption or uterine rupture.
研究者
相似试验
已完成
1 期
Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on CardiopathyDilated CardiomyopathyNCT01739777Universidad de los Andes, Chile30
已完成
1 期
Phase I clinical trial with umbilical cord-derived mesenchymal stromal cells (IMSUT-CORD) for treatment-resistant severe acute graft-versus-host disease (GVHD)First line treatment-resistant Grade II to IV acute graft-versus-host disease (GVHD)Acute graft-versus-host disease (GVHD)D006086, D000208JPRN-jRCT2033180077Tojo Arinobu6
已完成
1 期
Phase I clinical trial with umbilical cord-derived mesenchymal stromal cells (IMSUT-CORD) for treatment-resistant severe acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantatioFirst line treatment-resistant Grade II to IV acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantationJPRN-UMIN000032819The Institute of Medical Science, The University of Tokyo6
已完成
不适用
Umbilical Cord Milking for Neonates With Hypoxic Ischemic EncephalopathyHypoxic Ischemic EncephalopathyUmbilical Cord MilkingNCT02287077Thomas Jefferson University101
Unknown
1 期
Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes MellitusMesenchymal Stem CellsType 2 DiabetesNCT04441658Shanghai East Hospital30